Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Walking Impairment Questionnaire in PAD (WELCH)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2010 by University Hospital, Angers.
Recruitment status was:  Recruiting
Information provided by:
University Hospital, Angers Identifier:
First received: April 28, 2010
Last updated: June 24, 2010
Last verified: June 2010
Purpose is to test and validate a new questionnaire (the WELCH questionnaire) to estimate walking capacity in patients with claudication

Condition Intervention
Peripheral Artery Disease
Other: questionnaire

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Estimation de la capacité Fonctionnelle à la Marche Par Questionnaire Clinique Chez Des Patients adressés Pour un Test de Marche Sur Tapis Roulant

Further study details as provided by University Hospital, Angers:

Primary Outcome Measures:
  • scoring of the WELCH questionnaire [ Time Frame: 1 day ] [ Designated as safety issue: No ]
    predetermined score for the WELCH questionnaire answers (4 questions)

Estimated Enrollment: 400
Study Start Date: November 2009
Estimated Study Completion Date: November 2011
Estimated Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
patients referred for a treadmill test
Other: questionnaire
self completed questionnaire supervised by a technician

Detailed Description:
Questionnaires (WELCH and WIQ) submitted to patients referred for treadmill walking test Comparison of sore to MWD on treadmill. Comparison with WIQ will be performed

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients referred for treadmill testing

Inclusion Criteria:

  • informed consent signed, french language fluent patients

Exclusion Criteria:

  • rejection of the questionnaire
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01114178

University Hospital
Angers, France
Sponsors and Collaborators
University Hospital, Angers
Study Chair: denise Jolivot, MD University Hospital
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: abraham, University hospital Identifier: NCT01114178     History of Changes
Other Study ID Numbers: PL 2009/14 
Study First Received: April 28, 2010
Last Updated: June 24, 2010
Health Authority: France: Ministry of Health

Keywords provided by University Hospital, Angers:
peripheral artery disease

Additional relevant MeSH terms:
Peripheral Arterial Disease
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases
Peripheral Vascular Diseases processed this record on December 07, 2016